GLAM Project at Clinical Nanomedicine and Targeted Medicine Conference in Basel

CLINAM Glam Project
From the 26th to the 29th of June, the CLINAM (Clinical Nanomedicine and Targeted Medicine) Conference is taking place in Basel, Switzerland. The theme of this year’s edition is Enabling Technologies for Personalized Medicine. This event gathers various large European actors in the field of biotechnologies, medicine, and nanomedicine including the European Commission, nanomedicine, nanotox, EMRS, EMPA, and much more.

GLAM project will attend this event and present a poster to explain the latest research activities in the field of biosensors. If you would like to meet us there, do not hesitate to get in touch with us.

In the previous eight years, the CLINAM Summit grew to become the largest in its field, with 12 Nobel Laureates presenting and more than 500 participants from academia, industry, regulatory authorities, and policy from over 40 countries in Europe and worldwide. With this success and broad support from 31 renowned collaborating initiatives, the CLINAM Summit is today a key marketplace for scientific exchange and discussions of clinical, regulatory, political, and ethical aspects in this cutting-edge medicine field.

The CLINAM Summit emerged as an exquisite forum for translation from bench to bedside for European and international networking, industrial collaboration between companies and academia, and as a point of contact with customers. The summit is currently the only place to meet regulatory authorities from all continents to debate the needs of all stakeholders in this field. CLINAM 9/2016 continues its tradition of covering the interdisciplinary fields of Clinical and Targeted Nanomedicine in major and neglected diseases. As a special focus, CLINAM 09/2016 will address translation and enabling technologies, including cutting-edge molecular profiling, nano-scale analytics, single-cell analysis, stem cell technologies, tissue engineering, in vitro and ex vivo systems, as well as in vitro substitute systems for efficacy and toxicity testing.

CLINAM 09/2016 covers the spectrum of Nanomedicine and Targeted Medicine from new materials and enabling technologies to diagnostic and therapeutic translation and clinical applications in infectious, inflammatory, and neurodegenerative diseases, cancer, and regenerative medicine. It will also address societal implications, strategic issues, and regulatory affairs. The Summit is divided into four parallel tracks and provides ample opportunities for exhibitors to make decision-maker contacts. Nobel Laureate Prof. Stefan Hell will open the Summit. Participants are invited to bring samples to test the Stimulated Emission Depletion (STED) Microscopy within the exhibition.

The presence of a STED Microscope will give participants of CLINAM the opportunity to bring samples and investigate the revolutionary visibility. All participants will receive a link with label protocols before the Summit, providing information on how to prepare the samples. STED Microscopes are currently available on the market from companies like Abberior and Leica. This initiative to enable participants to investigate comes from CLINAM in cooperation with Beckman Coulter, Leica, and Abberior.

Últimas noticias

Categorías